Francesc Artigas - Publications

Affiliations: 
Barcelona Biomedical Research Institute, Barcelona, Catalunya, Spain 
Area:
Neuropharmacology

169 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Riga MS, Sanchez C, Celada P, Artigas F. Sub-chronic vortioxetine (but not escitalopram) normalizes brain rhythm alterations and memory deficits induced by serotonin depletion in rats. Neuropharmacology. 108238. PMID 32750446 DOI: 10.1016/j.neuropharm.2020.108238  0.6
2019 Amat-Foraster M, Celada P, Richter U, Jensen AA, Plath N, Artigas F, Herrik KF. Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat. Neuropharmacology. 107745. PMID 31445017 DOI: 10.1016/j.neuropharm.2019.107745  0.6
2018 Amat-Foraster M, Jensen AA, Plath N, Herrik KF, Celada P, Artigas F. Temporally dissociable effects of ketamine on neuronal discharge and gamma oscillations in rat thalamo-cortical networks. Neuropharmacology. PMID 29702122 DOI: 10.1016/j.neuropharm.2018.04.022  0.6
2017 Riga MS, Lladó-Pelfort L, Artigas F, Celada P. The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors. Neuropharmacology. PMID 29221792 DOI: 10.1016/j.neuropharm.2017.11.049  0.6
2017 van den Munkhof HE, Arnt J, Celada P, Artigas F. The antipsychotic drug brexpiprazole reverses phencyclidine-induced disruptions of thalamocortical networks. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 29128144 DOI: 10.1016/j.euroneuro.2017.10.034  0.6
2017 Santana N, Artigas F. Laminar and Cellular Distribution of Monoamine Receptors in Rat Medial Prefrontal Cortex. Frontiers in Neuroanatomy. 11: 87. PMID 29033796 DOI: 10.3389/fnana.2017.00087  0.48
2016 Artigas F, Schenker E, Celada P, Spedding M, Lladó-Pelfort L, Jurado N, Núñez M, Santana N, Troyano-Rodriguez E, Riga MS, van den Munkhof H, Castañé A, Shaban H, Jay TM, Tripathi A, et al. Defining the brain circuits involved in psychiatric disorders: IMI-NEWMEDS. Nature Reviews. Drug Discovery. PMID 27811930 DOI: 10.1038/nrd.2016.205  0.6
2016 Riga MS, Teruel-Martí V, Sánchez C, Celada P, Artigas F. Subchronic vortioxetine treatment -but not escitalopram- enhances pyramidal neuron activity in the rat prefrontal cortex. Neuropharmacology. PMID 27671324 DOI: 10.1016/j.neuropharm.2016.09.024  0.6
2016 Didriksen M, Fejgin K, Nilsson SR, Birknow MR, Grayton HM, Larsen PH, Lauridsen JB, Nielsen V, Celada P, Santana N, Kallunki P, Christensen KV, Werge TM, Stensbøl TB, Egebjerg J, ... ... Artigas F, et al. Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice. Journal of Psychiatry & Neuroscience : Jpn. 41: 150381. PMID 27391101 DOI: 10.1503/jpn.150381  0.6
2016 Santana N, Artigas F. Expression of Serotonin2C Receptors in Pyramidal and GABAergic Neurons of Rat Prefrontal Cortex: A Comparison with Striatum. Cerebral Cortex (New York, N.Y. : 1991). PMID 27252352 DOI: 10.1093/cercor/bhw148  0.48
2016 Mitchell E, Klein SL, Argyropoulos KV, Sharma A, Chan RB, Toth JG, Barboza L, Bavley C, Bortolozzi A, Chen Q, Liu B, Ingenito J, Mark W, Dudakov J, Gross S, ... ... Artigas F, et al. Behavioural traits propagate across generations via segregated iterative-somatic and gametic epigenetic mechanisms. Nature Communications. 7: 11492. PMID 27173585 DOI: 10.1038/ncomms11492  0.6
2016 Riga MS, Sánchez C, Celada P, Artigas F. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission. Neuropharmacology. PMID 27106166 DOI: 10.1016/j.neuropharm.2016.04.023  0.6
2016 Nilsson SR, Celada P, Fejgin K, Thelin J, Nielsen J, Santana N, Heath CJ, Larsen PH, Nielsen V, Kent BA, Saksida LM, Stensbøl TB, Robbins TW, Bastlund JF, Bussey TJ, ... Artigas F, et al. A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment. Psychopharmacology. PMID 26983414 DOI: 10.1007/s00213-016-4265-2  0.6
2015 Riga MS, Bortolozzi A, Campa L, Artigas F, Celada P. The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT1A and 5-HT2A receptors. Neuropharmacology. 101: 370-378. PMID 26477571 DOI: 10.1016/j.neuropharm.2015.10.016  0.6
2015 Castañé A, Santana N, Artigas F. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments. Psychopharmacology. 232: 4085-97. PMID 25943167 DOI: 10.1007/s00213-015-3946-6  0.48
2015 Castañé A, Kargieman L, Celada P, Bortolozzi A, Artigas F. 5-HT2A receptors are involved in cognitive but not antidepressant effects of fluoxetine. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1353-61. PMID 25914158 DOI: 10.1016/j.euroneuro.2015.04.006  0.6
2015 Puigdemont D, Portella M, Pérez-Egea R, Molet J, Gironell A, de Diego-Adeliño J, Martín A, Rodríguez R, Àlvarez E, Artigas F, Pérez V. A randomized double-blind crossover trial of deep brain stimulation of the subcallosal cingulate gyrus in patients with treatment-resistant depression: a pilot study of relapse prevention. Journal of Psychiatry & Neuroscience : Jpn. 40: 224-31. PMID 25652752 DOI: 10.1503/jpn.130295  0.6
2015 Sanchez C, Asin KE, Artigas F. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Pharmacology & Therapeutics. 145: 43-57. PMID 25016186 DOI: 10.1016/j.pharmthera.2014.07.001  0.6
2015 Artigas F. Developments in the field of antidepressants, where do we go now? European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 657-70. PMID 23706576 DOI: 10.1016/j.euroneuro.2013.04.013  0.6
2015 Ferrés-Coy A, Galofré M, Pilar-Cuéllar F, Vidal R, Paz V, Ruiz-Bronchal E, Campa L, Pazos, Caso JR, Leza JC, Alvarado G, Montefeltro A, Valdizán EM, Artigas F, Bortolozzi A. Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration Molecular Psychiatry. DOI: 10.1038/mp.2015.80  0.6
2015 Lladó-Pelfort L, Troyano-Rodriguez E, van den Munkhof HE, Cervera-Ferri A, Jurado N, Núñez-Calvet M, Artigas F, Celada P. Phencyclidine-induced disruption of oscillatory activity in prefrontal cortex: Effects of antipsychotic drugs and receptor ligands European Neuropsychopharmacology. DOI: 10.1016/j.euroneuro.2015.11.015  0.6
2015 Castañé A, Kargieman L, Celada P, Bortolozzi A, Artigas F. 5-HT2A receptors are involved in cognitive but not antidepressant effects of fluoxetine European Neuropsychopharmacology. 25: 1353-1361. DOI: 10.1016/j.euroneuro.2015.04.006  0.6
2015 Castañé A, Santana N, Artigas F. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments Psychopharmacology. DOI: 10.1007/s00213-015-3946-6  0.6
2014 Gomez-Sintes R, Bortolozzi A, Artigas F, Lucas JJ. Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1524-33. PMID 25088904 DOI: 10.1016/j.euroneuro.2014.07.004  0.6
2014 Alvarez E, Perez V, Artigas F. Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder. Neuropsychiatric Disease and Treatment. 10: 1297-307. PMID 25075188 DOI: 10.2147/NDT.S41387  0.6
2014 Troyano-Rodriguez E, Lladó-Pelfort L, Santana N, Teruel-Martí V, Celada P, Artigas F. Phencyclidine inhibits the activity of thalamic reticular gamma-aminobutyric acidergic neurons in rat brain. Biological Psychiatry. 76: 937-45. PMID 25038984 DOI: 10.1016/j.biopsych.2014.05.019  0.6
2014 Artigas F. Deep brain stimulation in major depression: plastic changes of 5-hydroxytryptamine neurons. Biological Psychiatry. 76: 174-5. PMID 25012045 DOI: 10.1016/j.biopsych.2014.05.008  0.6
2014 Riga MS, Soria G, Tudela R, Artigas F, Celada P. The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1269-82. PMID 24650558 DOI: 10.1017/S1461145714000261  0.6
2014 Mocci G, Jiménez-Sánchez L, Adell A, Cortés R, Artigas F. Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action. Neuropharmacology. 79: 49-58. PMID 24211653 DOI: 10.1016/j.neuropharm.2013.10.021  0.6
2014 Bortolozzi A, Celada P, Artigas F. Novel therapeutic strategies in major depression: focus on RNAi and ketamine. Current Pharmaceutical Design. 20: 3848-60. PMID 24180396  0.6
2014 Cano-Colino M, Almeida R, Gomez-Cabrero D, Artigas F, Compte A. Serotonin regulates performance nonmonotonically in a spatial working memory network. Cerebral Cortex (New York, N.Y. : 1991). 24: 2449-63. PMID 23629582 DOI: 10.1093/cercor/bht096  0.6
2014 Schäfer KVR, Tripathee R, Artigas F, Morin TH, Bohrer G. Carbon dioxide fluxes of an urban tidal marsh in the Hudson-Raritan estuary Journal of Geophysical Research G: Biogeosciences. 119: 2065-2081. DOI: 10.1002/2014JG002703  0.01
2013 Frazer A, Artigas F. Preclinical models of schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 2129. PMID 24369034 DOI: 10.1017/S1461145713001181  0.6
2013 Hensler JG, Artigas F, Bortolozzi A, Daws LC, De Deurwaerdère P, Milan L, Navailles S, Koek W. Catecholamine/Serotonin interactions: systems thinking for brain function and disease. Advances in Pharmacology (San Diego, Calif.). 68: 167-97. PMID 24054145 DOI: 10.1016/B978-0-12-411512-5.00009-9  0.6
2013 Celada P, Lladó-Pelfort L, Santana N, Kargieman L, Troyano-Rodriguez E, Riga MS, Artigas F. Disruption of thalamocortical activity in schizophrenia models: relevance to antipsychotic drug action. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 2145-63. PMID 23809188 DOI: 10.1017/S1461145713000643  0.6
2013 Celada P, Bortolozzi A, Artigas F. Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research. Cns Drugs. 27: 703-16. PMID 23757185 DOI: 10.1007/s40263-013-0071-0  0.6
2013 Celada P, Puig MV, Artigas F. Serotonin modulation of cortical neurons and networks. Frontiers in Integrative Neuroscience. 7: 25. PMID 23626526 DOI: 10.3389/fnint.2013.00025  0.6
2013 Artigas F. Future directions for serotonin and antidepressants. Acs Chemical Neuroscience. 4: 5-8. PMID 23336036 DOI: 10.1021/cn3001125  0.6
2013 Ferrés-Coy A, Pilar-Cuellar F, Vidal R, Paz V, Masana M, Cortés R, Carmona MC, Campa L, Pazos A, Montefeltro A, Valdizán EM, Artigas F, Bortolozzi A. RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis. Translational Psychiatry. 3: e211. PMID 23321808 DOI: 10.1038/tp.2012.135  0.6
2013 Santana N, Mengod G, Artigas F. Expression of α(1)-adrenergic receptors in rat prefrontal cortex: cellular co-localization with 5-HT(2A) receptors. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 1139-51. PMID 23195622 DOI: 10.1017/S1461145712001083  0.6
2013 Artigas F. Serotonin receptors involved in antidepressant effects. Pharmacology & Therapeutics. 137: 119-31. PMID 23022360 DOI: 10.1016/j.pharmthera.2012.09.006  0.6
2013 Ferrés-Coy A, Santana N, Castañé A, Cortés R, Carmona MC, Toth M, Montefeltro A, Artigas F, Bortolozzi A. Acute 5-HT₁A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions. Psychopharmacology. 225: 61-74. PMID 22820867 DOI: 10.1007/s00213-012-2795-9  0.6
2012 Masana M, Santana N, Artigas F, Bortolozzi A. Dopamine neurotransmission and atypical antipsychotics in prefrontal cortex: a critical review. Current Topics in Medicinal Chemistry. 12: 2357-74. PMID 23279176  0.6
2012 Masana M, Castañé A, Santana N, Bortolozzi A, Artigas F. Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies. Neuropharmacology. 63: 675-84. PMID 22652058 DOI: 10.1016/j.neuropharm.2012.05.020  0.6
2012 Bortolozzi A, Castañé A, Semakova J, Santana N, Alvarado G, Cortés R, Ferrés-Coy A, Fernández G, Carmona MC, Toth M, Perales JC, Montefeltro A, Artigas F. New antidepressant strategy based on acute siRNA silencing of 5-HT1A autoreceptors. Molecular Psychiatry. 17: 567. PMID 22617870 DOI: 10.1038/mp.2012.52  0.6
2012 Lladó-Pelfort L, Assié MB, Newman-Tancredi A, Artigas F, Celada P. In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat. Psychopharmacology. 221: 261-72. PMID 22147258 DOI: 10.1007/s00213-011-2569-9  0.6
2012 Scorza MC, Lladó-Pelfort L, Oller S, Cortés R, Puigdemont D, Portella MJ, Pérez-Egea R, Alvarez E, Celada P, Pérez V, Artigas F. Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment. British Journal of Pharmacology. 167: 1021-34. PMID 22050051 DOI: 10.1111/j.1476-5381.2011.01770.x  0.6
2012 Kargieman L, Riga MS, Artigas F, Celada P. Clozapine Reverses Phencyclidine-Induced Desynchronization of Prefrontal Cortex through a 5-HT(1A) Receptor-Dependent Mechanism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 723-33. PMID 22012474 DOI: 10.1038/npp.2011.249  0.6
2012 Lladó-Pelfort L, Santana N, Ghisi V, Artigas F, Celada P. 5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons. Cerebral Cortex (New York, N.Y. : 1991). 22: 1487-97. PMID 21893679 DOI: 10.1093/cercor/bhr220  0.6
2012 Bortolozzi A, Castañé A, Semakova J, Santana N, Alvarado G, Cortés R, Ferrés-Coy A, Fernández G, Carmona MC, Toth M, Perales JC, Montefeltro A, Artigas F. Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects. Molecular Psychiatry. 17: 612-23. PMID 21808255 DOI: 10.1038/mp.2011.92  0.6
2012 Puigdemont D, Pérez-Egea R, Portella MJ, Molet J, de Diego-Adeliño J, Gironell A, Radua J, Gómez-Anson B, Rodríguez R, Serra M, de Quintana C, Artigas F, Álvarez E, Pérez V. Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 121-33. PMID 21777510 DOI: 10.1017/S1461145711001088  0.6
2012 Alvarez E, Perez V, Dragheim M, Loft H, Artigas F. A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 589-600. PMID 21767441 DOI: 10.1017/S1461145711001027  0.6
2012 López-Gil X, Jiménez-Sánchez L, Romón T, Campa L, Artigas F, Adell A. Importance of inter-hemispheric prefrontal connection in the effects of non-competitive NMDA receptor antagonists. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 945-56. PMID 21733285 DOI: 10.1017/S1461145711001064  0.6
2011 Artigas F. [Glutamatergic antidepressants? The intriguing antidepressant properties of ketamine]. Revista De Psiquiatrí́a Y Salud Mental. 4: 183-6. PMID 23446263 DOI: 10.1016/j.rpsm.2011.07.002  0.6
2011 Santana N, Troyano-Rodriguez E, Mengod G, Celada P, Artigas F. Activation of thalamocortical networks by the N-methyl-D-aspartate receptor antagonist phencyclidine: reversal by clozapine. Biological Psychiatry. 69: 918-27. PMID 21251645 DOI: 10.1016/j.biopsych.2010.10.030  0.6
2011 Portella MJ, de Diego-Adeliño J, Ballesteros J, Puigdemont D, Oller S, Santos B, Álvarez E, Artigas F, Pérez V. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression. The Journal of Clinical Psychiatry. 72: 962-9. PMID 21034693 DOI: 10.4088/JCP.09m05827blu  0.6
2011 Masana M, Bortolozzi A, Artigas F. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 53-68. PMID 20701825 DOI: 10.1017/S1461145710000908  0.6
2011 Vázquez-Borsetti P, Celada P, Cortés R, Artigas F. Simultaneous projections from prefrontal cortex to dopaminergic and serotonergic nuclei. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 289-302. PMID 20374686 DOI: 10.1017/S1461145710000349  0.6
2011 Portella MJ, Ballesteros J, Artigas F, Pérez V. Dr Portella and Colleagues reply Journal of Clinical Psychiatry. 72: 1558. DOI: 10.4088/JCP.11lr07366a  0.6
2010 Lladó-Pelfort L, Assié MB, Newman-Tancredi A, Artigas F, Celada P. Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors. British Journal of Pharmacology. 160: 1929-40. PMID 20649591 DOI: 10.1111/j.1476-5381.2010.00738.x  0.6
2010 Scorza MC, Castañé A, Bortolozzi A, Artigas F. Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801 Clz and MK-801 in KO1A mice. Neuropharmacology. 59: 112-20. PMID 20412811 DOI: 10.1016/j.neuropharm.2010.04.012  0.6
2010 Bortolozzi A, Masana M, Díaz-Mataix L, Cortés R, Scorza MC, Gingrich JA, Toth M, Artigas F. Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 1299-314. PMID 20158933 DOI: 10.1017/S146114571000009X  0.6
2010 Artigas F. The prefrontal cortex: a target for antipsychotic drugs. Acta Psychiatrica Scandinavica. 121: 11-21. PMID 20059453 DOI: 10.1111/j.1600-0447.2009.01455.x  0.6
2010 López-Gil X, Artigas F, Adell A. Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex. Current Pharmaceutical Design. 16: 502-15. PMID 19909228 DOI: 10.2174/138161210790361416  0.6
2009 Portella MJ, de Diego-Adeliño J, Puigdemont D, Pérez-Egea R, Alvarez E, Artigas F, Pérez V. Pindolol augmentation enhances response outcomes in first depressive episodes. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 516-9. PMID 19419845 DOI: 10.1016/j.euroneuro.2009.04.004  0.6
2009 Vázquez-Borsetti P, Cortés R, Artigas F. Pyramidal neurons in rat prefrontal cortex projecting to ventral tegmental area and dorsal raphe nucleus express 5-HT2A receptors. Cerebral Cortex (New York, N.Y. : 1991). 19: 1678-86. PMID 19029064 DOI: 10.1093/cercor/bhn204  0.6
2009 Canals I, Carmona MC, Amigó M, Barbera A, Bortolozzi A, Artigas F, Gomis R. A functional leptin system is essential for sodium tungstate antiobesity action. Endocrinology. 150: 642-50. PMID 18845634 DOI: 10.1210/en.2008-0881  0.6
2009 López-Gil X, Artigas F, Adell A. Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 487-99. PMID 18752722 DOI: 10.1017/S1461145708009267  0.6
2009 Santana N, Mengod G, Artigas F. Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cerebral Cortex (New York, N.Y. : 1991). 19: 849-60. PMID 18689859 DOI: 10.1093/cercor/bhn134  0.6
2008 Kargieman L, Santana N, Mengod G, Celada P, Artigas F. NMDA antagonist and antipsychotic actions in cortico-subcortical circuits. Neurotoxicity Research. 14: 129-40. PMID 19073421 DOI: 10.1007/BF03033805  0.6
2008 Castañé A, Artigas F, Bortolozzi A. The absence of 5-HT(1A) receptors has minor effects on dopamine but not serotonin release evoked by MK-801 in mice prefrontal cortex. Psychopharmacology. 200: 281-90. PMID 18594799 DOI: 10.1007/s00213-008-1205-9  0.6
2008 Celada P, Puig MV, Díaz-Mataix L, Artigas F. The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs. Biological Psychiatry. 64: 392-400. PMID 18436196 DOI: 10.1016/j.biopsych.2008.03.013  0.6
2008 Scorza MC, Meikle MN, Hill XL, Richeri A, Lorenzo D, Artigas F. Prefrontal cortex lesions cause only minor effects on the hyperlocomotion induced by MK-801 and its reversal by clozapine. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 11: 519-32. PMID 18248688 DOI: 10.1017/S1461145708008432  0.6
2008 Santana N, De Almeida J, Mengod G, Artigas F. Localization of 5-HT receptors in the mammalian cortex Serotonin and Sleep: Molecular, Functional and Clinical Aspects. 135-153. DOI: 10.1007/978-3-7643-8561-3_5  0.6
2008 Celada P, Castañé A, Adell A, Artigas F. Experimental Research Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application. 1: 449-489. DOI: 10.1002/9783527619337.ch9  0.6
2008 Artigas F. Introductory and Basic Aspects Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application. 1: 298-334. DOI: 10.1002/9783527619337.ch6  0.6
2008 De Lagrán MM, Bortolozzi A, Gispert J, Millán O, Artigas F, Fillat C, Dierssen MDM. Ageing in Down syndrome: DYRK1A as a candidate gene for cognitive decline | El envejecimiento en el síndrome de Down: Dyrk1A como gen candidato para el declive cognitivo Sd Revista Medica Internacional Sobre El Sindrome De Down. 12: 34-40.  0.6
2007 Kargieman L, Santana N, Mengod G, Celada P, Artigas F. Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine. Proceedings of the National Academy of Sciences of the United States of America. 104: 14843-8. PMID 17785415 DOI: 10.1073/pnas.0704848104  0.6
2007 Gómez-Sintes R, Hernández F, Bortolozzi A, Artigas F, Avila J, Zaratin P, Gotteland JP, Lucas JJ. Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice. The Embo Journal. 26: 2743-54. PMID 17510631 DOI: 10.1038/sj.emboj.7601725  0.6
2007 Toirac I, Sanjuán J, Aguilar EJ, González JC, Artigas F, Rivero O, Nájera C, Moltó MD, de Frutos R. Association between CCK-AR gene and schizophrenia with auditory hallucinations. Psychiatric Genetics. 17: 47-53. PMID 17413443 DOI: 10.1097/YPG.0b013e3280298292  0.6
2007 Amargós-Bosch M, Adell A, Artigas F. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex. Journal of Neurochemistry. 102: 550-61. PMID 17394545 DOI: 10.1111/j.1471-4159.2007.04532.x  0.6
2007 López-Gil X, Babot Z, Amargós-Bosch M, Suñol C, Artigas F, Adell A. Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2087-97. PMID 17356574 DOI: 10.1038/sj.npp.1301356  0.6
2007 Bortolozzi A, Díaz-Mataix L, Toth M, Celada P, Artigas F. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain. Psychopharmacology. 191: 745-58. PMID 17265076 DOI: 10.1007/s00213-007-0698-y  0.6
2007 Martinez de Lagran M, Bortolozzi A, Millan O, Gispert JD, Gonzalez JR, Arbones ML, Artigas F, Dierssen M. Dopaminergic deficiency in mice with reduced levels of the dual-specificity tyrosine-phosphorylated and regulated kinase 1A, Dyrk1A(+/-). Genes, Brain, and Behavior. 6: 569-78. PMID 17137466 DOI: 10.1111/j.1601-183X.2006.00285.x  0.6
2007 Celada P, Artigas F. Serotonin modulation of cortical activity Monoaminergic Modulation of Cortical Excitability. 67-89. DOI: 10.1007/978-0-387-72256-6_4  0.6
2006 Artigas F, Adell A, Celada P. Pindolol augmentation of antidepressant response. Current Drug Targets. 7: 139-47. PMID 16475955 DOI: 10.2174/138945006775515446  0.6
2006 Amargós-Bosch M, López-Gil X, Artigas F, Adell A. Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 9: 565-73. PMID 16316487 DOI: 10.1017/S1461145705005900  0.6
2006 Díaz-Mataix L, Artigas F, Celada P. Activation of pyramidal cells in rat medial prefrontal cortex projecting to ventral tegmental area by a 5-HT1A receptor agonist. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 288-96. PMID 16290106 DOI: 10.1016/j.euroneuro.2005.10.003  0.6
2006 Artigas F. Review: An early sustained response can occur in the first and second weeks of antidepressant treatment for major depressive disorder - Commentary Evidence-Based Mental Health. 9: 78. DOI: 10.1136/ebmh.9.3.78  0.6
2006 Artigas F, Adell A. Chapter 6.3 The use of brain microdialysis in antidepressant drug research Handbook of Behavioral Neuroscience. 16: 527-543. DOI: 10.1016/S1569-7339(06)16028-2  0.6
2005 Díaz-Mataix L, Scorza MC, Bortolozzi A, Toth M, Celada P, Artigas F. Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 10831-43. PMID 16306396 DOI: 10.1523/JNEUROSCI.2999-05.2005  0.6
2005 Bortolozzi A, Díaz-Mataix L, Scorza MC, Celada P, Artigas F. The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. Journal of Neurochemistry. 95: 1597-607. PMID 16277612 DOI: 10.1111/j.1471-4159.2005.03485.x  0.6
2005 Amargós-Bosch M, Artigas F, Adell A. Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex. European Journal of Pharmacology. 516: 235-8. PMID 15967429 DOI: 10.1016/j.ejphar.2005.05.004  0.6
2005 Pineda JR, Canals JM, Bosch M, Adell A, Mengod G, Artigas F, Ernfors P, Alberch J. Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease. Journal of Neurochemistry. 93: 1057-68. PMID 15934928 DOI: 10.1111/j.1471-4159.2005.03047.x  0.6
2005 Marek GJ, Martin-Ruiz R, Abo A, Artigas F. The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 2205-15. PMID 15886717 DOI: 10.1038/sj.npp.1300762  0.6
2005 Adell A, Castro E, Celada P, Bortolozzi A, Pazos A, Artigas F. Strategies for producing faster acting antidepressants. Drug Discovery Today. 10: 578-85. PMID 15837601 DOI: 10.1016/S1359-6446(05)03398-2  0.6
2005 Puig MV, Artigas F, Celada P. Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. Cerebral Cortex (New York, N.Y. : 1991). 15: 1-14. PMID 15238448 DOI: 10.1093/cercor/bhh104  0.6
2004 Puig MV, Celada P, Artigas F. [Serotonergic control of prefrontal cortex]. Revista De Neurologia. 39: 539-47. PMID 15467993  0.6
2004 Celada P, Puig M, Amargós-Bosch M, Adell A, Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. Journal of Psychiatry & Neuroscience : Jpn. 29: 252-65. PMID 15309042  0.6
2004 Adell A, Artigas F. The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems. Neuroscience and Biobehavioral Reviews. 28: 415-31. PMID 15289006 DOI: 10.1016/j.neubiorev.2004.05.001  0.6
2004 Puig MV, Santana N, Celada P, Mengod G, Artigas F. In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors. Cerebral Cortex (New York, N.Y. : 1991). 14: 1365-75. PMID 15166106 DOI: 10.1093/cercor/bhh097  0.6
2004 Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F. Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cerebral Cortex (New York, N.Y. : 1991). 14: 1100-9. PMID 15115744 DOI: 10.1093/cercor/bhh070  0.6
2004 Bortolozzi A, Amargós-Bosch M, Toth M, Artigas F, Adell A. In vivo efflux of serotonin in the dorsal raphe nucleus of 5-HT1A receptor knockout mice. Journal of Neurochemistry. 88: 1373-9. PMID 15009637  0.6
2004 Amargós-Bosch M, Bortolozzi A, Puig MV, Serrats J, Adell A, Celada P, Toth M, Mengod G, Artigas F. Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cerebral Cortex (New York, N.Y. : 1991). 14: 281-99. PMID 14754868 DOI: 10.1093/cercor/bhg128  0.6
2004 Serrats J, Artigas F, Mengod G, Cortés R. An autoradiographic study of the influence of pindolol upon [35S]GTPgammaS binding in rat, guinea pig and human brain. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 7: 27-34. PMID 14720318 DOI: 10.1017/S1461145703003924  0.6
2003 Bortolozzi A, Amargós-Bosch M, Adell A, Díaz-Mataix L, Serrats J, Pons S, Artigas F. In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs. The European Journal of Neuroscience. 18: 1235-46. PMID 12956722 DOI: 10.1046/j.1460-9568.2003.02829.x  0.6
2003 Puig MV, Celada P, Díaz-Mataix L, Artigas F. In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents. Cerebral Cortex (New York, N.Y. : 1991). 13: 870-82. PMID 12853374 DOI: 10.1093/cercor/13.8.870  0.6
2003 Messa C, Colombo C, Moresco RM, Gobbo C, Galli L, Lucignani G, Gilardi MC, Rizzo G, Smeraldi E, Zanardi R, Artigas F, Fazio F. 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharmacology. 167: 72-8. PMID 12632246 DOI: 10.1007/s00213-002-1379-5  0.6
2003 Romero L, Celada P, Martín-Ruiz R, Díaz-Mataix L, Mourelle M, Delgadillo J, Hervás I, Artigas F. Modulation of serotonergic function in rat brain by VN2222, a serotonin reuptake inhibitor and 5-HT1A receptor agonist. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 445-56. PMID 12629524 DOI: 10.1038/sj.npp.1300062  0.6
2003 Bortolozzi A, Artigas F. Control of 5-hydroxytryptamine release in the dorsal raphe nucleus by the noradrenergic system in rat brain. Role of alpha-adrenoceptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 421-34. PMID 12629522 DOI: 10.1038/sj.npp.1300061  0.6
2003 Serrats J, Artigas F, Mengod G, Cortés R. GABAB receptor mRNA in the raphe nuclei: co-expression with serotonin transporter and glutamic acid decarboxylase. Journal of Neurochemistry. 84: 743-52. PMID 12562519 DOI: 10.1046/j.1471-4159.2003.01557.x  0.6
2003 Amargós-Bosch M, Adell A, Bortolozzi A, Artigas F. Stimulation of α1-adrenoceptors in the rat medial prefrontal cortex increases the local in vivo 5-hydroxytryptamine release: Reversal by antipsychotic drugs Journal of Neurochemistry. 87: 831-842. DOI: 10.1046/j.1471-4159.2003.02044.x  0.6
2002 Celada P, Puig MV, Martín-Ruiz R, Casanovas JM, Artigas F. Control of the serotonergic system by the medial prefrontal cortex: potential role in the etiology of PTSD and depressive disorders. Neurotoxicity Research. 4: 409-419. PMID 12754155 DOI: 10.1080/10298420290030550  0.6
2002 Miró X, Pérez-Torres S, Artigas F, Puigdomènech P, Palacios JM, Mengod G. Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study. Neuropharmacology. 43: 1148-57. PMID 12504921 DOI: 10.1016/S0028-3908(02)00220-4  0.6
2002 Artigas F, Nutt DJ, Shelton R. Mechanism of action of antidepressants. Psychopharmacology Bulletin. 36: 123-32. PMID 12490828  0.6
2002 Adell A, Celada P, Abellán MT, Artigas F. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Research. Brain Research Reviews. 39: 154-80. PMID 12423765 DOI: 10.1016/S0165-0173(02)00182-0  0.6
2002 Celada P, Casanovas JM, Paez X, Artigas F. Control of serotonergic neurons in the dorsal raphe nucleus by the lateral hypothalamus. Brain Research. 932: 79-90. PMID 11911864 DOI: 10.1016/S0006-8993(02)02284-9  0.6
2001 Artigas F. Limitations to enhancing the speed of onset of antidepressants - are rapid action antidepressants possible? Human Psychopharmacology. 16: 29-36. PMID 12404595 DOI: 10.1002/hup.180  0.6
2001 Celada P, Puig MV, Casanovas JM, Guillazo G, Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 9917-29. PMID 11739599  0.6
2001 Martín-Ruiz R, Puig MV, Celada P, Shapiro DA, Roth BL, Mengod G, Artigas F. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 9856-66. PMID 11739593  0.6
2001 Artigas F, Celada P, Adell A. Sympathomimetic effects of pindolol in depression [1] (multiple letters) Trends in Pharmacological Sciences. 22: 554-555. PMID 11698094  0.6
2001 Adell A, Celada P, Artigas F. The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain. Journal of Neurochemistry. 79: 172-82. PMID 11595769 DOI: 10.1046/j.1471-4159.2001.00550.x  0.6
2001 Artigas F, Celada P, Laruelle M, Adell A. How does pindolol improve antidepressant action? Trends in Pharmacological Sciences. 22: 224-8. PMID 11339972 DOI: 10.1016/S0165-6147(00)01682-5  0.6
2001 Martín-Ruiz R, Ugedo L, Honrubia MA, Mengod G, Artigas F. Control of serotonergic neurons in rat brain by dopaminergic receptors outside the dorsal raphe nucleus. Journal of Neurochemistry. 77: 762-75. PMID 11331405 DOI: 10.1046/j.1471-4159.2001.00275.x  0.6
2001 Lucas G, Di Matteo V, De Deurwaerdère P, Porras G, Martín-Ruiz R, Artigas F, Esposito E, Spampinato U. Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function. The European Journal of Neuroscience. 13: 889-98. PMID 11264661 DOI: 10.1046/j.0953-816X.2000.01453.x  0.6
2001 Zanardi R, Artigas F, Moresco R, Colombo C, Messa C, Gobbo C, Smeraldi E, Fazio F. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. Journal of Clinical Psychopharmacology. 21: 53-8. PMID 11199948 DOI: 10.1097/00004714-200102000-00010  0.6
2001 Pérez V, Puiigdemont D, Gilaberte I, Alvarez E, Artigas F. Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors. Journal of Clinical Psychopharmacology. 21: 36-45. PMID 11199945 DOI: 10.1097/00004714-200102000-00008  0.6
2001 Hervás I, Vilaró MT, Romero L, Scorza MC, Mengod G, Artigas F. Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 24: 11-20. PMID 11106871 DOI: 10.1016/S0893-133X(00)00175-5  0.6
2000 Abellán MT, Martín-Ruiz R, Artigas F. Local modulation of the 5-HT release in the dorsal striatum of the rat: an in vivo microdialysis study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 10: 455-62. PMID 11115735 DOI: 10.1016/S0924-977X(00)00118-8  0.6
2000 Casanovas JM, Berton O, Celada P, Artigas F. In vivo actions of the selective 5-HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release. Naunyn-Schmiedeberg's Archives of Pharmacology. 362: 248-54. PMID 10997727 DOI: 10.1007/s002100000291  0.6
2000 Goodnick PJ, Kumar AM, Artigas F, Perez V, Alvarez E. Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression (multiple letters) Biological Psychiatry. 47: 846-847. PMID 10819459  0.6
2000 Abellán MT, Adell A, Honrubia MA, Mengod G, Artigas F. GABAB-RI receptors in serotonergic neurons: effects of baclofen on 5-HT output in rat brain. Neuroreport. 11: 941-5. PMID 10790860  0.6
2000 Hervás I, Queiroz CM, Adell A, Artigas F. Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat. British Journal of Pharmacology. 130: 160-6. PMID 10781012 DOI: 10.1038/sj.bjp.0703297  0.6
2000 Sacristán JA, Gilaberte I, Boto B, Buesching DP, Obenchain RL, Demitrack M, Pérez Sola V, Alvarez E, Artigas F. Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial. International Clinical Psychopharmacology. 15: 107-13. PMID 10759342  0.6
2000 Abellán MT, Jolas T, Aghajanian GK, Artigas F. Dual control of dorsal raphe serotonergic neurons by GABA(B) receptors. Electrophysiological and microdialysis studies. Synapse (New York, N.Y.). 36: 21-34. PMID 10700023 DOI: 10.1002/(SICI)1098-2396(200004)36:1<21::AID-SYN3>3.0.CO;2-D  0.6
2000 Gobbo C, Zanardi R, Messa C, Artigas F, Moresco RM, Colombo C, Rizzo G, Panzacchi A, Smeraldi E, Fazio F. 5-HT2 receptors in depressed patients studied by [F-18]FESP and PET: Effects of depressive symptoms Neuroimage. 11: S75.  0.6
1999 Bel N, Artigas F. Modulation of the extracellular 5-hydroxytryptamine brain concentrations by the serotonin and noradrenaline reuptake inhibitor, milnacipran. Microdialysis studies in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 21: 745-54. PMID 10633480 DOI: 10.1016/S0893-133X(99)00076-7  0.6
1999 Figueras G, Pérez V, San Martino O, Alvarez E, Artigas F. Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Grupo de Trastornos Afectivos. Biological Psychiatry. 46: 518-24. PMID 10459402 DOI: 10.1016/S0006-3223(98)00344-8  0.6
1999 Raurich A, Mengod G, Artigas F, Cortés R. Displacement of the binding of 5-HT(1A) receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain. Synapse (New York, N.Y.). 34: 68-76. PMID 10459173 DOI: 10.1002/(SICI)1098-2396(199910)34:1<68::AID-SYN8>3.0.CO;2-Z  0.6
1999 Ugedo L, Pineda J, Martín-Ruiz R, Ruiz-Ortega JA, Artigas F. Imidazoline-induced inhibition of firing rate of 5-HT neurons in rat dorsal raphe by modulation of extracellular 5-HT levels. Annals of the New York Academy of Sciences. 881: 365-8. PMID 10415938 DOI: 10.1111/j.1749-6632.1999.tb09382.x  0.6
1999 Adell A, Artigas F. Regulation of the release of 5-hydroxytryptamine in the median raphe nucleus of the rat by catecholaminergic afferents. The European Journal of Neuroscience. 11: 2305-11. PMID 10383619 DOI: 10.1046/j.1460-9568.1999.00642.x  0.6
1999 Casanovas JM, Hervás I, Artigas F. Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex. Neuroreport. 10: 1441-5. PMID 10380960  0.6
1999 Pérez V, Soler J, Puigdemont D, Alvarez E, Artigas F. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius. Archives of General Psychiatry. 56: 375-9. PMID 10197835  0.6
1999 Casanovas JM, Vilaró MT, Mengod G, Artigas F. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain. Journal of Neurochemistry. 72: 262-72. PMID 9886078 DOI: 10.1046/j.1471-4159.1999.0720262.x  0.6
1998 Adell A, Artigas F. A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat. British Journal of Pharmacology. 125: 1361-7. PMID 9863668 DOI: 10.1038/sj.bjp.0702206  0.6
1998 Hervás I, Artigas F. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors. European Journal of Pharmacology. 358: 9-18. PMID 9809863 DOI: 10.1016/S0014-2999(98)00579-2  0.6
1998 Hervás I, Bel N, Fernández AG, Palacios JM, Artigas F. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei. Naunyn-Schmiedeberg's Archives of Pharmacology. 358: 315-22. PMID 9774218 DOI: 10.1007/PL00005259  0.6
1998 Dugast C, Soulière F, Schmitt P, Casanovas JM, Fattaccini CM, Mocaër E, Lesourd M, Renaud B, Artigas F, Hamon M, Chouvet G. Is the potent 5-HT1A receptor agonist, alnespirone (S-20499), affecting dopaminergic systems in the rat brain? European Journal of Pharmacology. 350: 171-80. PMID 9696405 DOI: 10.1016/S0014-2999(98)00254-4  0.6
1998 Pérez V, Bel N, Celada P, Ortiz J, Alvarez E, Artigas F. Relationship between blood serotonergic variables, melancholic traits, and response to antidepressant treatments. Journal of Clinical Psychopharmacology. 18: 222-30. PMID 9617981  0.6
1997 Casanovas JM, Lésourd M, Artigas F. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain. British Journal of Pharmacology. 122: 733-41. PMID 9375971 DOI: 10.1038/sj.bjp.0701420  0.56
1997 Cañas N, Sanchis D, Gómez G, Casanovas JM, Artigas F, Fernández-López JA, Remesar X, Alemany X. 3-Hydroxybutyrate co-infused with noradrenaline decreases resulting plasma levels of noradrenaline in Wistar rats. The Journal of Experimental Biology. 200: 2641-6. PMID 9359370  0.56
1997 Adell A, Casanovas JM, Artigas F. Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology. 36: 735-41. PMID 9225300  0.56
1997 Romero L, Artigas F. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors. Journal of Neurochemistry. 68: 2593-603. PMID 9166757  0.6
1996 Romero L, Bel N, Casanovas JM, Artigas F. Two actions are better than one: avoiding self-inhibition of serotonergic neurones enhances the effects of serotonin uptake inhibitors. International Clinical Psychopharmacology. 11: 1-8. PMID 8923121  0.56
1996 Artigas F, Bel N, Casanovas JM, Romero L. Adaptative changes of the serotonergic system after antidepressant treatments. Advances in Experimental Medicine and Biology. 398: 51-9. PMID 8906240  0.56
1996 Gardier AM, Malagié I, Trillat AC, Jacquot C, Artigas F. Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundamental & Clinical Pharmacology. 10: 16-27. PMID 8900496  0.6
1996 Manzo L, Artigas F, Martínez E, Mutti A, Bergamaschi E, Nicotera P, Tonini M, Candura SM, Ray DE, Costa LG. Biochemical markers of neurotoxicity. A review of mechanistic studies and applications. Human & Experimental Toxicology. 15: S20-35. PMID 8882557  0.6
1996 Casanovas JM, Artigas F. Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways. Journal of Neurochemistry. 67: 1945-52. PMID 8863499  0.56
1994 Celada P, Martín F, Artigas F. Effects of chronic treatment with dexfenfluramine on serotonin in rat blood, brain and lung tissue. Life Sciences. 55: 1237-43. PMID 7934621  0.6
1994 Celada P, Bel N, Artigas F. The effects of brofaromine, a reversible MAO-A inhibitor, on extracellular serotonin in the raphe nuclei and frontal cortex of freely moving rats. Journal of Neural Transmission. Supplementum. 41: 357-63. PMID 7931251  0.6
1994 Romero L, Celada P, Artigas F. Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/G(o) proteins in dorsal raphe nucleus. European Journal of Pharmacology. 265: 103-6. PMID 7883021  0.6
1993 Cortés R, Mengod G, Celada P, Artigas F. p-chlorophenylalanine increases tryptophan-5-hydroxylase mRNA levels in the rat dorsal raphe: a time course study using in situ hybridization. Journal of Neurochemistry. 60: 761-4. PMID 8419551  0.6
1993 Celada P, Artigas F. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat. Naunyn-Schmiedeberg's Archives of Pharmacology. 347: 583-90. PMID 7689703  0.6
1993 Celada P, Artigas F. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues. Journal of Neurochemistry. 61: 2191-8. PMID 7504085  0.6
1992 Celada P, Dolera M, Alvarez E, Artigas F. Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement. Journal of Affective Disorders. 25: 243-9. PMID 1385505  0.6
1992 Celada P, Pérez J, Alvarez E, Artigas F. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement. Journal of Clinical Psychopharmacology. 12: 309-15. PMID 1282522  0.6
1991 Sarrias MJ, Martínez E, Celada P, Udina C, Alvarez E, Artigas F. Plasma free 5HT and platelet 5HT in depression: case-control studies and the effect of antidepressant therapy. Advances in Experimental Medicine and Biology. 294: 653-8. PMID 1722955  0.6
1991 Ortiz J, Celada P, Martínez E, Artigas F. Plasma free 5HT, plasma 5HIAA and whole blood 5HT in the rat. Advances in Experimental Medicine and Biology. 294: 447-50. PMID 1722947  0.6
1990 Celada P, Sarrias MJ, Artigas F. Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity. Journal of Neural Transmission. Supplementum. 32: 149-54. PMID 1708403  0.6
Show low-probability matches.